Subject of the day
VIMIAN.ST
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through four segments: Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, education, and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and surgical and dental products to veterinary clinics and universities, including dentistry and companion animal orthopedics under the Movora brand name. Vimian Group AB (publ) was incorporated in 2020 and is headquartered in Stockholm, Sweden.
| Line | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | $107.50M | $104.30M | $109.00M | $116.00M |
| Gross profit | $74.80M | $72.10M | $73.70M | $81.10M |
| Operating income | $15.60M | $14.50M | $19.30M | $21.10M |
| Net income | $4.30M | $8.30M | $12.10M | $9.80M |
| Diluted EPS | 0.01 | 0.02 | 0.02 | 0.02 |
| Free cash flow | $13.90M | $19.10M | $49.90M | $16.20M |
| CapEx | -$3.20M | -$3.10M | -$5.80M | -$6.80M |
$35.10
▼ -0.20 (-0.6%)
| 52w hi | $35.35 |
|---|---|
| 52w lo | $24.92 |
| Vol | 375.53K |
| As of | Aug 13 |
Our score +0.11
| Short | -0.10 |
|---|---|
| Medium | +0.22 |
| Long | +0.30 |
computed 2026-08-13
Vimian Group AB (publ)
Healthcare · Diagnostics & Research
| Market cap | $18.72B |
|---|---|
| Enterprise value | $256.32M |
| Trailing P/E | 46.04x |
| Forward P/E | 26.65x |
| EV / EBITDA | 2.24x |
| P / S (ttm) | 41.52x |
| Profit margin | 8.2% |
| Return on equity | 5.3% |
| Revenue growth | +16.6% |
| Earnings growth | +0.2% |
| Debt / equity | 37.40 |
| Beta vs SPX | 0.11 |
|---|---|
| Corr SPX | 0.04 |
| Annual vol | 41.8% |
| Annual ret | +10.4% |
| Sharpe | 0.25 |
| Max DD | -49.9% |
Window: 504 trading days (490 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.24 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $34.70 | $35.80 | $34.70 | — | 375.53K |
| Aug 12 | $35.10 | $35.60 | $34.90 | $35.10 | 82.30K |
| Aug 11 | $35.35 | $35.90 | $35.25 | $35.30 | 468.68K |
| Aug 10 | $35.50 | $35.55 | $34.75 | $35.35 | 404.55K |
| Aug 7 | $34.85 | $35.75 | $34.70 | $35.10 | 103.68K |